Skip to Content

APO MYC360 (Mycophenolic acid delayed-release 360 mg)

Pill imprint APO MYC360 has been identified as Mycophenolic acid delayed-release 360 mg.

Mycophenolic acid is used in the treatment of dermatomyositis; rejection prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolic acid 360 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolic acid delayed-release 360 mg APO MYC360
Mycophenolic acid delayed-release 360 mg APO MYC360
Discount Card Promo
Mycophenolic acid delayed-release
Imprint:
APO MYC360
Strength:
360 mg
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Corp.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide